EarlyTox Cardiotoxicity Kit Provides Biologically Relevant Cardiotoxicity Data Earlier in the Drug Discovery Process

This study demonstrates that the EarlyTox Cardiotoxicity Kit has been optimized to provide a robust, high throughput method for measuring the impact of pharmacological compounds on stem cell derived cardiomyocytes.